Henk‐Jan Westeneng

2.0k citations

27 papers · 676 indexed · h-index 14

Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 23
- Parkinson's Disease Mechanisms and Treatments 12
- Neurological diseases and metabolism 2
Genetics top 5%
- Neurogenetic and Muscular Disorders Research 13
Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 23
- Parkinson's Disease Mechanisms and Treatments 12
- Neurological diseases and metabolism 2
Cellular and Molecular Neuroscience
- Genetic Neurodegenerative Diseases 4
Physiology
- Alzheimer's disease research and treatments 4
Molecular Biology
- RNA modifications and cancer 2
- Mitochondrial Function and Pathology 2

Co-authors: Jan H. Veldink Leonard H. van den Berg Michael A. van Es Adrian J. Waite Raymond D. Schellevis Renata Vieira de Sá R. Jeroen Pasterkamp Max Koppers
Cited by: Neurology Genetics
Journals: Neurology (2 papers)Annals of Neurology (5 papers)The Lancet Neurology (1 paper)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Henk‐Jan Westeneng

25 papers receiving 670 citations

Peers

Countries citing papers authored by Henk‐Jan Westeneng

Since Specialization

Citations

This map shows the geographic impact of Henk‐Jan Westeneng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk‐Jan Westeneng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk‐Jan Westeneng more than expected).

Fields of papers citing papers by Henk‐Jan Westeneng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk‐Jan Westeneng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk‐Jan Westeneng. The network helps show where Henk‐Jan Westeneng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henk‐Jan Westeneng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henk‐Jan Westeneng Line = papers co-authored together Henk‐Jan Westeneng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multimodal Neuroimaging‐Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi‐Cohort Analysis Human Brain Mapping ·Tobias R. Baumeister,Henk‐Jan Westeneng,Leonard van den Berg,Sanjay Kalra,Yasser Iturria‐Medina	2025	0
2	Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis NeuroImage Clinical ·Harold H G Tan,Abram D. Nitert,Kevin van Veenhuijzen,Stefan Dukic,M.J.E. van Zandvoort,Jeroen Hendrikse,Michael A. van Es,Jan H. Veldink,Henk‐Jan Westeneng,Leonard H. van den Berg	2025	3
3	Altered EEG Response of the Parietal Network in Asymptomatic C9orf72 Carriers Human Brain Mapping ·Stefan Dukic,Kevin van Veenhuijzen,Henk‐Jan Westeneng,Roisin McMackin,Ruben P. A. van Eijk,Boudewijn T.H.M. Sleutjes,Bahman Nasseroleslami,Orla Hardiman,Leonard H. van den Berg	2025	1
4	Cognitive impairment within and beyond the FTD spectrum in ALS: development of a complementary cognitive screen Journal of Neurology ·Annebelle Michielsen,Kevin van Veenhuijzen,Fenna Hiemstra,(unknown),Boaz Kalkhoven,Jan H. Veldink,Esther T. Kruitwagen‐van Reenen,Michael A. van Es,M.J.E. van Zandvoort,Leonard H. van den Berg,Henk‐Jan Westeneng	2025	2
5	Longitudinal Magnetic Resonance Imaging in Asymptomatic C9orf72 Mutation Carriers Distinguishes Phenoconverters to Amyotrophic Lateral Sclerosis or Amyotrophic Lateral Sclerosis With Frontotemporal Dementia Annals of Neurology ·Kevin van Veenhuijzen,Harold H G Tan,Abram D. Nitert,Michael A. van Es,Jan H. Veldink,Leonard H. van den Berg,Henk‐Jan Westeneng	2024	5
6	Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis Journal of Neurology Neurosurgery & Psychiatry ·Abram D. Nitert,Harold H G Tan,Renée Walhout,Nienke L Knijnenburg,Michael A. van Es,Jan H. Veldink,Jeroen Hendrikse,Henk‐Jan Westeneng,Leonard H. van den Berg	2021	16
7	Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study The Lancet Neurology ·Henk‐Jan Westeneng,Kevin van Veenhuijzen,Rick A. A. van der Spek,Susan Peters,Anne E Visser,Wouter van Rheenen,Jan H. Veldink,Leonard H. van den Berg	2021	37
8	Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy Journal of the Neurological Sciences ·Marta García‐Montojo,Saeed Fathi,Gina Norato,Bryan Smith,Dominic B. Rowe,Matthew C. Kiernan,Steve Vucic,Susan Mathers,Ruben P. A. van Eijk,Ulisses A. Santamaria,Mary‐Louise Rogers,Andrea Malaspina,Vittoria Lombardi,Puja R. Mehta,Henk‐Jan Westeneng,Leonard H. van den Berg,Ammar Al‐Chalabi,Julian Gold,Avindra Nath	2021	34
9	Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study Journal of Neurology Neurosurgery & Psychiatry ·Mark R. Janse van Mantgem,Ruben P. A. van Eijk,Hannelore K. van der Burgh,Harold H G Tan,Henk‐Jan Westeneng,Michael A. van Es,Jan H. Veldink,Leonard H. van den Berg	2020	50
10	Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide BMC Neurology ·Remko M. van Eenennaam,Willeke J. Kruithof,Michael A. van Es,Esther T. Kruitwagen‐van Reenen,Henk‐Jan Westeneng,Johanna M. A. Visser‐Meily,Leonard H. van den Berg,Anita Beelen	2020	13
11	The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis Annals of Neurology ·Harold H G Tan,Henk‐Jan Westeneng,Hannelore K. van der Burgh,Michael A. van Es,Leonhard A. Bakker,Kevin van Veenhuijzen,Kristel R. van Eijk,Ruben P. A. van Eijk,Jan H. Veldink,Leonard H. van den Berg	2020	23
12	Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure? The Pharmacogenomics Journal ·Ruben P. A. van Eijk,Marinus J.C. Eijkemans,Stavros Nikolakopoulos,Marc Jansen,Henk‐Jan Westeneng,Kristel R. van Eijk,Rick A. A. van der Spek,Joke J.F.A. van Vugt,Sanne Piepers,Geert Jan Groeneveld,Jan H. Veldink,Leonard H. van den Berg,Michael A. van Es	2019	14
13	A continuous repetitive task to detect fatigability in spinal muscular atrophy Orphanet Journal of Rare Diseases ·Marloes Stam,Renske I. Wadman,Bart Bartels,Maureen Leeuw,Henk‐Jan Westeneng,Camiel A. Wijngaarde,Leonard H. van den Berg,W. Ludo van der Pol	2018	21
14	Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis Journal of Neurology Neurosurgery & Psychiatry ·Anne E Visser,James Rooney,Fabrizio D’Ovidio,Henk‐Jan Westeneng,Roel Vermeulen,Ettore Beghi,Adriano Chiò,Giancarlo Logroscino,Orla Hardiman,Jan H. Veldink,Leonard H. van den Berg	2018	43
15	Novel Gender Selective Survival Effect of C9orf72 in European ALS Cohorts (P5.093) Neurology ·James Rooney,Russell L. McLaughlin,Alice Vajda,Isabella Fogh,Ashley Jones,Henk‐Jan Westeneng,Mark Heverin,Ruben van Eijk,Wim Robberecht,Philip Van Damme,Leonard van den Berg,Jan H. Veldink,Ammar Al‐Chalabi,Adriano Chiò,Orla Hardiman	2016	2
16	C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits Annals of Neurology ·Max Koppers,Anna M. Blokhuis,Henk‐Jan Westeneng,Margo L. Terpstra,Caroline A. C. Zundel,Renata Vieira de Sá,Raymond D. Schellevis,Adrian J. Waite,Derek J. Blake,Jan H. Veldink,Leonard H. van den Berg,R. Jeroen Pasterkamp	2015	201
17	Cortical thickness in ALS: towards a marker for upper motor neuron involvement Journal of Neurology Neurosurgery & Psychiatry ·Renée Walhout,Henk‐Jan Westeneng,Esther Verstraete,Jeroen Hendrikse,Jan H. Veldink,Martijn P. van den Heuvel,Leonard H. van den Berg	2014	83
18	Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol BMC Neurology ·Saskia Lassche,Coen A. C. Ottenheijm,Nicol C. Voermans,Henk‐Jan Westeneng,Bárbara Janssen,Silvère M. van der Maarel,Maria T. E. Hopman,George W. Padberg,Ger J.M. Stienen,Baziel G.M. van Engelen	2013	12
19	MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level. PubMed ·H. M. de Wit,Henk‐Jan Westeneng,Baziel G.M. van Engelen,Aart Mudde	2012	19
20	PS2 - 8. MIDD or MELAS: that’s not the question. a severe clinical phenotype of the m.3243A>G mutation Heleen de Wit,Henk‐Jan Westeneng,Aart Mudde	2011	1

About Henk‐Jan Westeneng

Henk‐Jan Westeneng is a scholar working on Neurology, Genetics and Neurology, having authored 27 papers that have together received 676 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (23 papers), Neurogenetic and Muscular Disorders Research (13 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Alzheimer's disease research and treatments (4 papers), Genetic Neurodegenerative Diseases (4 papers), RNA modifications and cancer (2 papers), Neurological diseases and metabolism (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Neurology (551 citations), Genetics (342 citations) and Neurology (88 citations). Henk‐Jan Westeneng has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jan H. Veldink, Leonard H. van den Berg, Leonard H. van den Berg, Michael A. van Es, Adrian J. Waite, Raymond D. Schellevis, Renata Vieira de Sá, R. Jeroen Pasterkamp, Max Koppers and Anna M. Blokhuis. Their work appears in journals such as Neurology, Annals of Neurology and The Lancet Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact